Article

Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program.

2020-02-13

Abstract excerpt

<title>Abstract</title> <bold>Background: </bold>CIGB-247 is a cancer therapeutic vaccine that uses as antigen a variant of human vascular endothelial growth factor (VEGF) mixed with the bacterially-derived adjuvant VSSP. CIGB-247 has been already evaluated in two phase I clinical trials (CENTAURO and CENTAURO-2), showing to be safe and immunogenic in advanced cancer patients selected under well-defined and co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c8f40be2-d7b8-5ee2-98f4-a9a6f3d2ba90
DOI: 10.21203/rs.2.15817/v4

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program.DOI 10.21203/rs.2.15817/v4Read

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigenSemantic proximity Read

Evaluating Immunoreactivity of Polyclonal Antibodies Developed against AU-565 Cell Line for Diagnosis and Immunotherapy of Breast CancerSemantic proximity Read

Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapySemantic proximity Read

COVID-19–Sensitive Tumour Response – 2-Year Assessment of the SARS-CoV-2 Humoral Response in Cancer Patients in Oncology Hospital in PolandSemantic proximity Read

VEGF165b mutant can be used as a protein carrier to form a chimeric tumor vaccine with Mucin1 peptide to elicit an anti-tumor response.Semantic proximity Read

GB10, a best-in-class antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseasesSemantic proximity Read

Repeat Systemic Delivery of Cross-Neutralization Resistant Synthetic Vesiculoviruses Immunomodulates the Tumor MicroenvironmentSemantic proximity Read

Flagellin synergistically enhances anti-tumor effect of EGFRvIII peptide in a glioblastoma-bearing mouse brain tumor modelSemantic proximity Read

Transgenic goats producing an improved version of cetuximab in milkSemantic proximity Read

Next generation of anti-PD-L1 Atezolizumab with better anti-tumor efficacy in vivoSemantic proximity Read

Development of a Recombinant Monospecific Anti-PLGF Bivalent Nanobody and Evaluation of it in Angiogenesis Modulation.Semantic proximity Read

Adoptive In Situ Vaccination with Cyclical Intermittent Stereotactic Body Radiotherapy (SBRT) and Immunotherapy – a Review and Proposed StrategySemantic proximity Read